LUX HEALTH TECH ACQUISITION - COM CL A (LUXA)

CUSIP: 55068A100

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM CL A
Total 13F shares
30,772,492
Share change
+1,413,760
Total reported value
$304,348,768
Put/Call ratio
466%
Price per share
$9.89
Number of holders
70
Value change
+$14,021,485
Number of buys
34
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 55068A100?
CUSIP 55068A100 identifies LUXA - LUX HEALTH TECH ACQUISITION - COM CL A in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) as of Q2 2022

As of 30 Jun 2022, LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,772,492 shares. The largest 10 holders included Empyrean Capital Partners, LP, Sculptor Capital LP, Weiss Asset Management LP, Wolfswood Holdings, LLC, MARSHALL WACE, LLP, Balyasny Asset Management LLC, BANK OF MONTREAL /CAN/, Saba Capital Management, L.P., D. E. Shaw & Co., Inc., and MYDA Advisors LLC. This page lists 70 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.